| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/01/2010 | CN1969855B Pharmaceutical composition having target organ protection function and usage thereof |
| 09/01/2010 | CN1846721B Tranquilizing seven-leaf oral cavity disintegrated tablet and its preparation method |
| 09/01/2010 | CN101821263A Dipeptoid prodrugs and the use thereof |
| 09/01/2010 | CN101821261A Trisubstituted piperidines |
| 09/01/2010 | CN101820871A Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine |
| 09/01/2010 | CN101817940A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same |
| 09/01/2010 | CN101817872A Orally administered peptides synergize statin activity |
| 09/01/2010 | CN101817808A Flavones derivative as well as preparation method and application thereof as alpha1 receptor antagonist |
| 09/01/2010 | CN101816769A Medicament for treating cardiac, cerebral and vascular diseases |
| 09/01/2010 | CN101816746A Medicament for treating hypertension and preparation method thereof |
| 09/01/2010 | CN101816744A Energy-saving and environmentally-friendly method for preparing garlic oil cyclodextrine inclusion compound |
| 09/01/2010 | CN101816742A Chinese medicinal composition for treating hemorrhoids and preparation method thereof |
| 09/01/2010 | CN101816733A Sugar-free hawthorn and chrysanthemum preparation and preparation method thereof |
| 09/01/2010 | CN101816727A Chinese medicinal preparation for treating hemorrhoids |
| 09/01/2010 | CN101816704A Chinese medicinal composition for preventing and treating restenosis after percutaneous coronary artery intervention therapy (PCI) and preparation method thereof |
| 09/01/2010 | CN101816703A Medicinal composition for treating cardiac, cerebral and vascular diseases and preparation method thereof |
| 09/01/2010 | CN101816701A Process for preparing kudzu root extract instant grains |
| 09/01/2010 | CN101816699A Substituted tea for reducing blood pressure and blood fat and manufacturing method thereof |
| 09/01/2010 | CN101816698A Composition for preventing and curing metabolism disturbance syndrome |
| 09/01/2010 | CN101816692A Extraction method of chrysanthemum saponin |
| 09/01/2010 | CN101816667A Application of forsythiaside A in preparation of drugs for preventing and treating cardiovascular and cerebrovascular diseases |
| 09/01/2010 | CN101816657A Process for preparing vinegar powder soft capsules |
| 09/01/2010 | CN101816656A Formula of vinegar powder soft capsules |
| 09/01/2010 | CN101816655A Medicinal preparation containing repaglinide and ligustrazine and application thereof in diabetic complications |
| 09/01/2010 | CN101816654A Medicinal combination of nalmefene hydrochloride and polyvinyl pyrrolidone and preparation method thereof |
| 09/01/2010 | CN101816640A Prasugrel liposome solid preparation |
| 09/01/2010 | CN101816636A Isosorbide mononitrate freeze-dried power injection and preparation method thereof |
| 09/01/2010 | CN101816414A Application of sunflower leaves for preparing foods and health-care foods for reducing blood pressure in auxiliary way |
| 09/01/2010 | CN101375857B Application of yew polysaccharide in preparing medicament for myocardial ischemia-reperfusion injury |
| 09/01/2010 | CN101297672B Method for producing active peptides from enzymolysis of fish proteins using active enzymes in angleworm intestinal canal |
| 09/01/2010 | CN101279033B Preparation of soft capsules for curing coronary disease and cerebral arteriosclerosis |
| 09/01/2010 | CN101254284B Rheumatism treating medicine combination, preparation and quality control method |
| 09/01/2010 | CN101244117B Chinese patent medicine preparation for treating piles and preparation method thereof |
| 09/01/2010 | CN101229372B Medicine compounds for treating hypertension |
| 09/01/2010 | CN101229341B Medicine rapid healing hypertension merging hemiplegy |
| 09/01/2010 | CN101220006B Buflomedil production method |
| 09/01/2010 | CN101057678B Composition containing natural plant extraction or monomer |
| 09/01/2010 | CN101007794B N,N'-disubstituted piperazine derivative, and its preparation method and medicinal composition and uses |
| 08/31/2010 | US7786177 Phenylalanine enamide derivatives |
| 08/31/2010 | US7786175 Anti-atherosclerosis composition containing carotenoids and method for inhibiting LDL oxidation |
| 08/31/2010 | US7786135 Substituted pyrroline kinase inhibitors |
| 08/31/2010 | US7786131 Anticancer agents; restenosis; atherosclerosis; skin disorders |
| 08/31/2010 | US7786108 Compounds and method for treating dyslipidemia |
| 08/31/2010 | US7786106 such as 3-[(4-methoxybenzoyl)-amino]-2-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}phenyl beta -D-glucopyranoside, used as an activated blood coagulation factor X inhibitor; anticoagulants or preventive/therapeutic agents for diseases induced by thrombosis or embolism |
| 08/31/2010 | US7786102 Steroids as agonists for FXR |
| 08/31/2010 | US7786048 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 08/31/2010 | US7785886 Contacting ABC1-expressing cells with a composition containing test compound and measuring biological activity by determining the level of efflux of labeled substrate ; use in treating cardiovascular disease |
| 08/31/2010 | US7785870 Cell-specific expression/replication vector |
| 08/31/2010 | US7785835 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 08/31/2010 | US7785833 Methods and means for producing proteins with predetermined post-translational modifications |
| 08/31/2010 | US7785632 angiogenesis inhibitors; tetraiodothyroacetic acid conjugated to glycolide-lactide copolymer; binds cell surface receptor for thyroid hormone on integrin alpha at cell membrane level and does not activate signal transduction |
| 08/31/2010 | US7785614 For use against vascular diesases or graft rejection. |
| 08/31/2010 | US7785599 Albumin fusion proteins |
| 08/31/2010 | US7785596 administering galectins to the brain of the vertebrates to intensify in vivo proliferation of subventricular zone astrocytes and neuron stem cells; treatment of neurodegenerative diseases, brain and nervous system disorders |
| 08/31/2010 | US7785567 treatment of hypercholesterolemia or cardiovascular disease associated with atherosclerosis by administration of Growth Hormone Releasing Peptides to patient; reducing blood plasma cholesterol levels; modulating expression of scavenger receptor CD36 and genes involved in cellular cholesterol efflux |
| 08/31/2010 | CA2567981C Constrained himbacine analogs as thrombin receptor antagonists |
| 08/31/2010 | CA2480427C Novel potassium-dependent sodium-calcium exchanger |
| 08/31/2010 | CA2374226C Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives |
| 08/31/2010 | CA2332817C Il-6 antagonist peptides |
| 08/26/2010 | WO2010096722A1 3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors |
| 08/26/2010 | WO2010095808A2 Production method for astragalus membranaceus extract employing enzymolysis, and a composition for preventing or alleviating diabetes or obesity containing an active ingredient comprising an astragalus membranaceus extract produced by means of the production method |
| 08/26/2010 | WO2010095706A1 Novel anti-inflammatory compounds |
| 08/26/2010 | WO2010095690A1 Blood flow improving agent |
| 08/26/2010 | WO2010095663A1 Fused heterocyclic ring compound |
| 08/26/2010 | WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same |
| 08/26/2010 | WO2010076524A3 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 08/26/2010 | WO2010056041A3 Pharmaceutical composition for treating and preventing heart diseases caused by ischemia or ischemic reperfusion |
| 08/26/2010 | US20100217379 Implantable medical device comprising a pro-healing poly(ester-amide) |
| 08/26/2010 | US20100216893 Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate |
| 08/26/2010 | US20100216891 Aromatic antihypertensive agent, and method for lowering blood pressure in mammals |
| 08/26/2010 | US20100216886 Polymorphs of n2-(1,1'-biphenyl-4-ylcarbonyl)-n1-[2-(4-fluorophenyl)-1,1-dimethylethyl]-l-alpha-glutamine |
| 08/26/2010 | US20100216882 Aspirin-triggered lipid mediators |
| 08/26/2010 | US20100216871 Use of compounds having ccr antagonism |
| 08/26/2010 | US20100216866 RNAi Modulation of APOB and Uses Thereof |
| 08/26/2010 | US20100216865 MicroRNA COMPOSITIONS IN THE TREATMENT OF VEGF-MEDIATED DISORDERS |
| 08/26/2010 | US20100216863 Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment |
| 08/26/2010 | US20100216854 1,3 and 1,3,5 substituted imidazoles as antihypertensives |
| 08/26/2010 | US20100216844 Carboxamide compounds and their use as calpain inhibitors |
| 08/26/2010 | US20100216833 Tetrahydrocarbazoles and derivatives |
| 08/26/2010 | US20100216832 Method for Assaying FTO (2-Oxoglutarate Dependent Oxygenase) Activity |
| 08/26/2010 | US20100216818 Inhibitors of Post-Amadori Advanced Glycation End Products |
| 08/26/2010 | US20100216808 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 08/26/2010 | US20100216801 Thiazolones for use as pi3 kinase inhibitors |
| 08/26/2010 | US20100216789 Rho-kinase inhibitors |
| 08/26/2010 | US20100216786 New compounds |
| 08/26/2010 | US20100216785 Pharmaceutical compositions |
| 08/26/2010 | US20100216781 mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY |
| 08/26/2010 | US20100216764 Soluble Guanylate Cyclase Activators |
| 08/26/2010 | US20100216761 Novel azetidinones useful as inhibitors of elastase |
| 08/26/2010 | US20100216759 Novel 2-Azetidinone Derivatives And Their Use As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemia |
| 08/26/2010 | US20100216758 Pyridone Compounds |
| 08/26/2010 | US20100216739 Method of promoting muscle tissue repair |
| 08/26/2010 | US20100216728 New use of specific cyklolignans |
| 08/26/2010 | US20100216726 Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof |
| 08/26/2010 | US20100216724 Use of fibronectin fragment (196-203 ) as a therapeutic agent |
| 08/26/2010 | US20100216722 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent |
| 08/26/2010 | US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway |
| 08/26/2010 | US20100216715 FGF21 Derivatives With Albumin Binder A-B-C-D-E- And Their Use |
| 08/26/2010 | US20100216714 Natriuretic compounds, conjugates, and uses thereof |
| 08/26/2010 | US20100215779 Compositions and Methods for Treating Disorders Associated with Salt or Fluid Retention |